NDC 59368-003-01 - up and up dye free infants concentrated ibuprofen
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 59368-003
- Requested NDC
- 59368-003-01
- Package NDCs from labels
- 59368-003-01, 59368-003-02
- Manufacturer
- Sixarp, LLC
- Effective date
- 2024-03-15
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| up and up dye free infants concentrated ibuprofen - Sixarp, LLC | Sixarp, LLC | 2024-03-15 | HUMAN OTC DRUG LABEL |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Ibuprofen | IBUPROFEN | CHAIN DRUG MARKETING ASSOCIATION INC. | aa91952b-512f-0ead-e053-2995a90a9455 | 2022-12-21 | Warnings | WK2XYI10QM |
| Pediacare Childrens Ibuprofen Berry | IBUPROFEN | RANDOB LABS,LTD. DBA CROSSINGWELL CONSUMER HEALTH | 347d081f-068c-4173-9b4b-001ab2b891f5 | 2022-12-20 | Warnings | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | Bionpharma Inc. | ba89fbe6-546a-e10c-e053-2a95a90ade0c | 2022-12-20 | Warnings | WK2XYI10QM |
| pain relief pm | IBUPROFEN, DIPHENHYDRAMINE HCL | Bionpharma Inc. | 58666a5c-fc92-4c8d-9c04-f0c98dc05c56 | 2022-12-20 | Warnings | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | INGLES MARKETS, INC. | ef536841-768c-919f-e053-2a95a90af599 | 2022-12-12 | Warnings | WK2XYI10QM |
| Diphenhydramine HCl and Ibuprofen | DIPHENHYDRAMINE HCL AND IBUPROFEN | Aurohealth LLC | 39af6dfa-e822-43a5-bd1a-338cf5da89ce | 2022-12-09 | Warnings | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | Walgreens | 6bd8a0c2-314f-47cb-80cd-1d4dd92b209f | 2022-11-29 | Warnings | WK2XYI10QM |
| Refresh Digital PF | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN AND POLYSORBATE 80 | Allergan, Inc. | 97e83e68-6374-4df4-93f6-d707fc32748d | 2022-11-28 | Warnings | PDC6A3C0OX 6OZP39ZG8H |
| Refresh Digital | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN, POLYSORBATE 80 | Allergan, Inc. | b2bd34d4-fab9-4f4b-9be2-5d30b55f5b81 | 2022-11-28 | Warnings | PDC6A3C0OX 6OZP39ZG8H |
| Concentrated ibuprofen infants | IBUPROFEN | Guardian Drug Company | 3a32f0c7-c03e-4783-a429-08280993ddfb | 2022-11-28 | Warnings | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | TOPCO ASSOCIATES LLC | cef74c2f-0c23-609d-e053-2a95a90a6b8e | 2022-11-23 | Warnings | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | Care One (American Sales Company) | 016299ef-ad40-46fd-acfc-e74ffee3d9b4 | 2022-11-21 | Warnings | WK2XYI10QM |
| signature care childrens ibuprofen | IBUPROFEN | Safeway | c30fbb8f-a293-4f6e-9495-11402548fe2d | 2022-11-15 | Warnings | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | Dolgencorp, Inc. (DOLLAR GENERAL & REXALL) | 7f510feb-023c-4974-af6d-3e7a30cef362 | 2022-11-07 | Warnings | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | Dolgencorp, Inc. (DOLLAR GENERAL & REXALL) | 8de40427-1be3-4a86-bc4c-9659ebaa203f | 2022-11-07 | Warnings | WK2XYI10QM |
| Ibuprofen and Pseudoephedrine HCl | IBUPROFEN AND PSEUDOEPHEDRINE HCL | Amerisource Bergen | 8d397f4f-ac5e-426d-a26b-ee064b6e5028 | 2022-11-04 | Warnings | WK2XYI10QM |
| Anticoagulant Citrate Phosphate Dextrose (CPD) Blood-Pack Units in PL 146 Plastic | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE (CPD) SOLUTION | Fenwal, Inc. | d55cb701-9664-4931-8754-1a8cae68da06 | 2022-11-01 | XF417D3PSL | |
| Ibuprofen | IBUPROFEN | Proficient Rx LP | 9e9fb921-6b6a-422e-95b6-41d6b9047b80 | 2022-11-01 | Boxed warning, Warnings, Adverse reactions | WK2XYI10QM |
| CPDA-1 | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE (CPDA-1) SOLUTION | Fenwal, Inc. | f9d7f1b4-7a77-44f9-8924-10b16008b49d | 2022-11-01 | XF417D3PSL | |
| Anticoagulant Citrate Phosphate Dextrose (CPD) Blood-Pack Units in PL 146 Plastic | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE (CPD) | Fenwal, Inc. | 4a08a9ec-46a5-4fcf-80ee-5c33f1a8b746 | 2022-11-01 | XF417D3PSL |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.